Depression in older adults is often regarded as a separate mental health issue, but recent research indicates that brain changes might start before noticeable memory problems even appear. Scientists have discovered a connection between the accumulation of the tau protein and increasing depressive symptoms among seniors whose cognitive functions are still normal.
This study was led by Teodora Markova from Brandeis University and colleagues, and it was published in JNeurosci, the journal of the Society for Neuroscience. The researchers analyzed data from the Alzheimer’s Disease Neuroimaging Initiative, a comprehensive, long-term project studying brain aging and Alzheimer’s disease.
Alzheimer’s disease is primarily known for causing memory loss, confusion, and reasoning difficulties. However, mood and behavioral changes can also occur, sometimes years before a formal diagnosis. Because of this, researchers are interested in whether emotional shifts in later life could offer clues about underlying brain changes. Depression, in particular, is significant since it is common among seniors and can stem from various causes.
Tau is a protein that normally supports nerve cells in the brain. In Alzheimer’s disease, tau can undergo abnormal changes and gather inside brain cells, eventually forming structures that disrupt normal cell functions. These pathological tau changes are key biological markers studied in Alzheimer’s research. Another hallmark is the buildup of amyloid protein in the brain.
For this study, the team examined older men and women with varying levels of cognitive health. Some participants had normal memory and thinking skills, while others had mild cognitive impairment or Alzheimer’s. They underwent multiple brain scans designed to detect tau levels and completed questionnaires assessing depressive symptoms across several visits, which enabled the researchers to analyze how mood and tau build-up relate over time.
Findings revealed that among individuals with preserved cognitive abilities, those with a faster increase in tau also tended to experience a more rapid rise in depressive symptoms. Elevated tau levels were associated with higher depression scores, and the timing suggested that tau accumulation preceded the onset of mood changes.
This indicates that early tau-related brain changes might contribute to mood alterations before noticeable issues with memory or thinking surface. However, it’s important to note that depression in older adults does not automatically signal the early stages of Alzheimer’s disease. Many factors—such as stress, loneliness, physical health conditions, sleep disturbances, medication effects, and biological factors—can all cause depression.
The study also found that this pattern was not present in participants who already had mild cognitive impairment or Alzheimer’s, implying that the connection between tau and mood may be especially relevant at earlier stages of brain aging. Once cognitive decline begins, other brain changes occur simultaneously, making it more difficult to identify a direct link between tau and depressive symptoms.
These insights could eventually help researchers develop better ways to identify individuals at higher risk for neurodegenerative diseases. Monitoring mood changes over several years, alongside memory testing, brain scans, blood tests, and other assessments, might improve early detection efforts. Still, depression questionnaires alone cannot diagnose Alzheimer’s, and experiencing depressive symptoms doesn’t necessarily mean someone is developing the disease. Continued screening and proper care remain crucial.
Markova emphasized that longer-term studies are needed to track participants and determine if early tau buildup combined with rising depression increases the likelihood of later memory problems or clinical depression. Researchers also aim to compare mood shifts with other markers of Alzheimer’s, which could eventually clarify who is at risk and when disease-related changes begin.
The study’s strengths include repeated brain scans and consistent assessments of depressive symptoms over time. Tracking both changes longitudinally offers more meaningful insights than single measurements. Nevertheless, these findings should be viewed as preliminary clues rather than diagnostic tools. While there is a relationship observed in cognitively healthy older adults, more research is necessary to confirm whether changes in mood can reliably predict future Alzheimer’s disease.
Overall, the findings support the idea that brain changes associated with Alzheimer’s may start well before memory loss becomes evident. Mood might be one aspect of that early process, but it must be considered alongside biological markers, cognitive tests, medical history, and other factors to form a complete picture.
















